Jiewen Peng

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Shaodong Hong, Yaxiong Zhang, Gengsheng Yu et al. · Journal of Clinical Oncology · 2021 · 95 citations · Full text

Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet

Gui‐Nan Lin, Jiewen Peng, Jianjun Xiao et al. · Medical Oncology · 2014 · 67 citations

Lymphocyte-to-monocyte Ratio, Prognostic Biomarkers, Prognostic Impact +10

Elevated neutrophil‐to‐lymphocyte ratio predicts poor outcome in patients with advanced non‐small‐cell lung cancer receiving first‐line gefitinib or erlotinib treatment

Gui‐Nan Lin, Jiewen Peng, Panpan Liu et al. · Asia-Pacific Journal of Clinical Oncology · 2014 · 51 citations

A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)

Xingsheng Hu, Baohui Han, Aiqin Gu et al. · Lung Cancer · 2014 · 49 citations

Medicine, Pharmacology, Phase Iv Study +6

Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy

Gui‐Nan Lin, Jiewen Peng, Dongying Liu et al. · Tumor Biology · 2014 · 45 citations